<DOC>
<DOCNO>EP-0655945</DOCNO> 
<TEXT>
<INVENTION-TITLE>
METHOD FOR FABRICATING MICROPARTICLES IN EMULSION BY MODIFICATION OF THE CHEMICAL COMPOSITION OF THE DISPERSED PHASE AFTER EMULSIFICATION
</INVENTION-TITLE>
<CLASSIFICATIONS>A23L103	B01J1314	B01J1320	B01J1312	A61J307	B01J1308	A61J307	B01J1306	A23L1035	B01J1320	B01J1310	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A23L	B01J	B01J	B01J	A61J	B01J	A61J	B01J	A23L	B01J	B01J	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A23L1	B01J13	B01J13	B01J13	A61J3	B01J13	A61J3	B01J13	A23L1	B01J13	B01J13	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
COLETICA
</APPLICANT-NAME>
<APPLICANT-NAME>
COLETICA
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
LEVY MARIE-CHRISTINE
</INVENTOR-NAME>
<INVENTOR-NAME>
ORLY ISABELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
PERRIER ERIC
</INVENTOR-NAME>
<INVENTOR-NAME>
LEVY, MARIE-CHRISTINE
</INVENTOR-NAME>
<INVENTOR-NAME>
ORLY, ISABELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
PERRIER, ERIC
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A process for the manufacture of microparticles, in particular
microcapsules, characterised in that an essentially homogeneous solution of a

substance or mixture of substances in a solvent is first prepared, an emulsion of
the solution is produced in a dispersing liquid forming a continuous phase, in

which said substance or said mixture is essentially insoluble, and forming a
disperse phase, and a chemical or physicochemical reaction is then initiated in the

disperse phase by modification of the 
in situ
 chemical composition of said
substance or said mixture in the disperse phase through the addition of an agent

which is essentially insoluble in or immiscible with the continuous phase, under
the conditions of addition, thereby modifying the physicochemical state resulting

in the insolubilization of the substance or mixture of substances and in the
individualization of said microparticles, in the presence of the starting solvent,

said microparticles then being recovered.
A process according to claim 1, characterised in that the agent which
is essentially insoluble in or immiscible with the continuous phase, under the

conditions of addition, and which it is desired to incorporate into the disperse
phase is present as a solution in a solvent which is miscible with the solvent of the

disperse phase and which has a lower affinity for the dispersing liquid of the
continuous phase than for the disperse phase.
A process according to claim 1 or 2, characterised in that a substance
selected from nucleic acids, a protein or a polysaccharide, or various mixtures of

these substances, is used as the abovementioned substance or mixture of
substances.
A process according to claims 1 to 3, characterised in that the
formation of covalent bonds, in particular esterifications and amidations, or the

formation of ionic bonds between the ionizable groups of a substance or mixture
of substances is effected as the chemical reaction.
A process according to one of claims 1 to 3, characterised in that a
reaction selected from a coacervation, precipitation or insolubilization reaction is

effected as the physicochemical reaction.
A process according to one of claims 1 to 5, characterised in that the
abovementioned agent which is essentially insoluble in or immiscible with the

continuous phase causes a phase separation within the initially homogeneous 
solution of the disperse phase, the gelling of said solution of the disperse phase or

a loss of solubility of the disperse phase by condensation or polymerization.
A process according to one of claims 1 to 3 or 6, characterised in that
the abovementioned agent which is essentially insoluble in or immiscible with the

continuous phase, under the conditions of addition, is a non-solvent for the
substance or mixture of substances solubilized in the solvent of the disperse phase,

or said agent causes a pH modification, or said agent comprises at least one
electrolyte, or said agent comprises at least one molecule capable of reacting with

the substance or substances dissolved in the disperse phase of the emulsion.
A process according to one of claims 1 to 3 or 5 to 7, characterised in
that the non-solvent for the substance or mixture of substances solubilized in the

solvent of the disperse phase, which is essentially immiscible with the continuous
phase under the conditions of addition, causes insolubilization of the disperse

phase, in particular gelling or coagulation.
A process according to one of claims 5 to 8, characterised in that the
non-solvent is selected from an alcohol, in particular a C
1
-C
6
 lower alcohol,
preferably ethyl alcohol, or a ketone, in particular a C
2
-C
6
 lower ketone,
preferably acetone.
A process according to one of the preceding claims, characterised in
that the following successive steps are performed:


a) an aqueous solution of a substance selected from nucleic acids, a
protein or a polysaccharide, or various mixtures of these substances, is prepared;
b) a hydrophobic liquid is provided in which the abovementioned
substance or substances are essentially insoluble;
c) the hydrophobic liquid and the aqueous phase are mixed to form an
emulsion in which the aqueous solution is the disperse phase and the hydrophobic

liquid is the continuous phase;
d) the non-solvent for the substance solubilized in the disperse phase
is added to the emulsion in 
proportions such that said non-solvent is essentially
immiscible with the continuous phase, thereby forming microparticles by gelling

or coagulation;
e) the microparticles formed by said gelling or said coagulation are
collected by physical separation means, for example by filtration, centrifugation or

decantation; and 
f) the cohesion of the microparticles is preferably strengthened by
crosslinking.
A process according to one of claims 1 to 3 or 7, characterised in that
the first step is to produce an emulsion of an aqueous solution of a substance or

mixture of substances capable of undergoing, by a chemical or physicochemical
reaction, a variation in physicochemical state represented by insolubilization

caused by a pH modification, at a pH at which the physicochemical state of said
substance or said mixture of substances is that of a solution whose viscosity is

appropriate for the production of an emulsion; the pH is then varied by the
addition of the abovementioned insoluble or immiscible agent, comprising a pH-modifying

substance dissolved in an organic solvent miscible with the aqueous
phase, in order to initiate the chemical or physicochemical reaction and bring the

substance or mixture of substances into a physicochemical state which
corresponds to insolubilization of the substance or mixture and which results in

the formation of physically individualized microparticles.
A process according to claim 11, characterised in that the pH-modifying
substance used is an acid, a base or a buffer, depending on the desired

pH value.
A process according to claim 11 or 12, characterised in that the
following successive steps are performed:


a) an aqueous solution of a substance selected from nucleic acids, a
polysaccharide or a protein, or various mixtures of these substances, is prepared,

the pH being chosen so that the substance or mixture of substances forms an
essentially homogeneous solution whose viscosity is compatible with the

production of an emulsion;
b) a hydrophobic liquid is provided in which the abovementioned
substance or substances are essentially insoluble;
c) the hydrophobic liquid and the aqueous phase are mixed to form an
emulsion;
d) either a solution of an alkaline substance in an organic liquid
miscible with the aqueous phase is added to the emulsion, if it is desired to render

the aqueous phase alkaline, or a solution of an acid substance in an organic liquid
miscible with the aqueous phase is added to the emulsion, if it is desired to acidify

the aqueous phase; 
e) after a predetermined period of time required to effect the
coacervation of the initially solubilized substance or substances, the microparticles

formed are collected by centrifugation or filtration; and
f) the cohesion of the microparticles is preferably strengthened by
crosslinking.
A process according to claim 13, characterised in that the agent used
for crosslinking the abovementioned polyamino, polycarboxylic or polyhydroxylic

compounds or a mixture thereof is a difunctional agent such as formaldehyde,
glutaraldehyde and dialdehydes, acid dichlorides, acid dianhydrides, diisocyanates,

diimidoesters, bischloroformates and succinimides, or an agent which activates
carboxyl groups to form amide bonds with the amino groups or ester bonds with

the alcohol groups of the substance or mixture of substances, such as a
carbodiimide or an azide.
A process according to any one of the preceding claims, characterised
in that the protein used is preferably selected from collagen or a collagen

derivative, preferably atelocollagen, or the polysaccharide used is preferably
selected from a glycosaminoglycan or chitosan.
A process according to one of claims 1 to 4 and 5, characterised in
that a chemical transacylation reaction is carried out which takes place at alkaline

pH between a polysaccharide carrying esterified carboxyl groups and either a
polyamino substance, for example a protein, or a polyhydroxylic substance, for

example a polysaccharide carrying hydroxyl groups.
A process according to claim 16, characterised in that it comprises the
following steps:


a) a neutral, 
i.e.
 unreactive, aqueous solution is prepared which
contains on the one hand a polysaccharide carrying esterified carboxyl groups and

on the other hand either a polyamino substance, for example a protein, or a
polyhydroxylic substance, for example a polysaccharide carrying hydroxyl groups;
b) a hydrophobic liquid is provided in which the esterified
polysaccharide and the polyamino or polyhydroxylic substance are essentially

insoluble;
c) the hydrophobic liquid and the aqueous solution are mixed to form
an emulsion;
d) a solution of an alkaline substance in an organic liquid miscible
with the aqueous phase is added to the emulsion, making it possible to obtain 

physicochemical conditions favorable to the reaction between the polyamino
substance or the polyhydroxylic substance and the polysaccharide carrying

esterified carboxyl groups; and
e) after a predetermined period of time required to effect a
transacylation reaction, thereby forming microparticles, in particular

microcapsules, the emulsion is neutralized, preferably by the addition, to the
emulsion, of a solution of an acid substance in an organic liquid miscible with the

aqueous phase, which neutralizes and stabilizes the microparticles formed, in
particular the microcapsules formed.
A process according to claim 17, characterised in that the emulsion
formed is an emulsion of the aqueous solution as the disperse phase in the

hydrophobic liquid forming the continuous phase.
A process according to one of claims 1 to 18, characterised in that the
substance used is a polysaccharide which is capable of associating specifically

with an ion or a polyion to form a gel, said polysaccharide preferably being
selected from kappa- and iota-carrageenan, a pectin with a low degree of

methylation, an alginate and gellan gum preferably having a high molecular
weight of at least 500,000 daltons.
A process according to claim 19, characterised in that gellan is used in
aqueous solution at a concentration of between 0.1 and 5% and preferably of about

0.6% (w/v).
A process according to claim 19 or 20, characterised in that an
ethanolic solution is produced which contains calcium, magnesium, sodium or

potassium ions so that the solution is brought to an ion concentration of between 1
and 400 mM.
A process according to claim 19, characterised in that kappa- or iota-carrageenan,
which gels in the presence of potassium or calcium ions respectively,

is used; the carrageenan is dissolved in the cold, at neutral or alkaline pH, in
concentrations of between 0.1 and 5% (w/v), the temperature is raised to around

80°C and an emulsion is produced by dispersion in a hydrophobic liquid; gelling
of the droplets is then caused by the addition of an alcoholic solution containing

potassium or calcium ions, according to whether the aqueous solution contains
kappa- or iota-carrageenan.
A process according to claim 19, characterised in that the
polysaccharide used is a pectin with a low degree of methylation, which forms 

solutions gellable in the presence of calcium ions, the pectin solution being

produced at a concentration of between 0.1 and 10% (w/v) in the cold at neutral
pH, an emulsion is then produced by dispersion in a hydrophobic liquid and,

finally, calcium ions are then added in the form of an alcoholic solution of calcium
chloride.
A process according to claim 19, characterised in that the
polysaccharide used is a 1 to 5% (w/v) solution of sodium alginate.
Microparticles, in particular microcapsules, characterised in that they
are produced from substances or mixtures of substances comprising carboxyl

groups, amino groups and/or alcohol groups that are crosslinked by an activator
following the activation of the carboxyl groups with no bridges being formed so as

to form amide bonds with the amino groups and/or ester bonds with the alcohol
groups.
Microparticles or microcapsules, characterised in that the
microparticles comprise in bulk the reaction product between a polysaccharide

carrying esterified carboxyl groups and either a polyamino substance, such as for
example a protein, or a polyhydroxylic substance, such as for example a

polysaccharide; said microcapsules have a wall consisting of the reaction product
between a polysaccharide carrying esterified carboxyl groups and either a

polyamino substance, such as for example a protein, or a polyhydroxylic
substance, such as for example a polysaccharide.
Microparticles, in particular microcapsules according to one of claims
25 or 26, characterised in that the abovementioned substance or substances are

chosen from the group consisting of a protein, a polysaccharide or a nucleic acid,
mixtures of proteins, mixtures of polysaccharides or mixtures of proteins or

polysaccharides, optionally with nucleic acids.
Microparticles, in particular microcapsules according to one of claims
25 or 27, characterised in that the proteins are chosen from the group consisting of

α-lactalbumin, β-lactoglobulin, caseins, ovalbumin, animal albumins, blood
globulins, hemoglobin, fibrinogen, collagen, atelocollagen, gelatin, keratin,

vegetable albumins, vegetable globulins, glutenins and gliadin; the protein extracts
derived from milk, silk, cereals, leguminous plants, algae and fish; the

abovementioned polysaccharide is chosen from the group consisting of agar,
agarose, agaropectin, carrageenans, alginates, pectins, amylose, amylopectin,

starch, modified starches, galactomannans (such as guar, carob), glucomannan, 
konjac, modified celluloses, inulin, xanthan, dextran, curdlan, gellan, chitosan,

chondroitin sulfates, hyaluronic acid, dermatan sulfate, heparan sulfate, heparin,
keratan sulfate; nucleic acid is chosen from ribonucleic acid and deoxyribonucleic

acid.
Microparticles, in particular microcapsules according to one of claims
25 to 28, characterised in that the abovementioned polysaccharide associates

specifically with cations or polycations to form a gel.
Microparticles, in particular microcapsules according to claim 29,
characterised in that the abovementioned polysaccharide is chosen from the group

consisting of a kappa- or iota-carrageenan, a pectin with a low degree of
methylation, an alginate and a gellan gum.
Microparticles or microcapsules according to one of claims 25 to 30,
characterised in that the esterified polysaccharide is a propylene glycol alginate or

a pectin with a low degree of methylation, which forms a solution gellable in the
presence of calcium ions.
Microparticles or microcapsules according to one of claims 25 to 31,
characterised in that the abovementioned polyamino or polyhydroxylic substance

is chosen from human serum albumin, gelatin, whey proteins, ovalbumin, an
atelocollagen and chondroitin sulfate or carboxymethyl cellulose mixture.
Microparticles, in particular microcapsules, according to one of claims
25 to 32, characterised in that they are lyophilized.
A composition such as a cosmetic composition, a pharmaceutical
composition or a food composition, characterised in that it comprises

microparticles, in particular microcapsules, such as defined in any one of claims
25 to 33, or such as obtained by the process according to any one of claims 1 to

24.
</CLAIMS>
</TEXT>
</DOC>
